Börse:
94,490€
2,37%
Echtzeit-Aktienkurs Mirati Therapeutics
Bid:
94,090€
Ask:
94,890€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 3,07 Mrd. EUR (32,54 Mio. x 94,490€) | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| KUV | - | - | 237,86 |
| KGV | - | - | - |
| Div. Rend. | - | - | - |
Echtzeit-Chart der Mirati Therapeutics Aktie
Börsenkurse Mirati Therapeutics
| Euro Indikation | 94,090€ | 0 | 94,890€ | 0 | 94,490€ | 2,37% |
| Tradegate | 94,110 | 63 | 94,940 | 63 | 94,525 | 2,41% |
| Börse Stuttgart | 94,090€ | 0 | 94,890€ | 0 | 94,490€ | 0,65% |
| Dollar Indikation | 105,616$ | 0 | 106,514$ | 0 | 106,065$ | 0,17% |
Fundamentaldaten der Mirati Therapeutics Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 12,93 Mio. | -98,42 Mio. | -98,42 Mio. | -3,19 | 0,00% | - | 237,86 |
| 2017 | 0,00 Mio. | -70,43 Mio. | -70,43 Mio. | -2,78 | 0,00% | - | - |
| 2016 | 0,00 Mio. | -83,12 Mio. | -83,12 Mio. | -4,20 | 0,00% | - | - |
Profil der Mirati Therapeutics Aktie
Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company focuses on developing a pipeline of oncology products to treat genetic and epigenetic drivers of cancer in selected subsets of cancer patients .Its product candidates include glesatinib, sitravatinib and mocetinostat. The company was founded on December 13, 1995 and is headquartered in San Diego, CA.
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen